Skin substitutes from cultured cells and collagen-GAG polymers
- PMID: 10367473
- DOI: 10.1007/BF02518886
Skin substitutes from cultured cells and collagen-GAG polymers
Abstract
Engineering skin substitutes provides a potential source of advanced therapies for the treatment of acute and chronic wounds. Cultured skin substitutes (CSS) consisting of human keratinocytes and fibroblasts attached to collagen-glycosaminoglycan substrates have been designed and tested in preclinical and clinical studies. Cell culture techniques follow general principles of primary culture and cryopreservation in liquid nitrogen for long-term storage. Biopolymer substrates are fabricated from xenogeneic (bovine) collagen and glycosaminoglycan that are lyophilised for storage until use. At maturity in air-exposed culture, CSS develop an epidermal barrier that is not statistically different from native human skin, as measured by surface electrical capacitance. Preclinical studies in athymic mice show rapid healing, expression of cytokines and regulation of pigmentation. Clinical studies in burn patients demonstrate a qualitative outcome with autologous skin that is not different from 1:4 meshed, split-thickness autograft skin, and with a quantitative advantage over autograft skin in the ratio of healed skin to biopsy areas. Chronic wounds resulting from diabetes or venous stasis have been closed successfully with allogeneic CSS prepared from cryopreserved skin cells. These results define the therapeutic benefits of cultured skin substitutes prepared with skin cells from the patient or from cadaver donors. Future directions include genetic modification of transplanted cells to improve wound healing transiently or to deliver gene products systemically.
Similar articles
-
Reduced engraftment and wound closure of cryopreserved cultured skin substitutes grafted to athymic mice.Cryobiology. 1997 Sep;35(2):132-42. doi: 10.1006/cryo.1997.2030. Cryobiology. 1997. PMID: 9299104
-
Surface electrical capacitance as a noninvasive index of epidermal barrier in cultured skin substitutes in athymic mice.J Invest Dermatol. 1996 Jul;107(1):82-7. doi: 10.1111/1523-1747.ep12298286. J Invest Dermatol. 1996. PMID: 8752844
-
Incubation of cultured skin substitutes in reduced humidity promotes cornification in vitro and stable engraftment in athymic mice.Wound Repair Regen. 1999 Jul-Aug;7(4):226-37. doi: 10.1046/j.1524-475x.1999.00226.x. Wound Repair Regen. 1999. PMID: 10781214
-
Principles and practices for treatment of cutaneous wounds with cultured skin substitutes.Am J Surg. 2002 Apr;183(4):445-56. doi: 10.1016/s0002-9610(02)00813-9. Am J Surg. 2002. PMID: 11975935 Review.
-
Tissue-engineered skin. Current status in wound healing.Am J Clin Dermatol. 2001;2(5):305-13. doi: 10.2165/00128071-200102050-00005. Am J Clin Dermatol. 2001. PMID: 11721649 Review.
Cited by
-
Basic Quality Controls Used in Skin Tissue Engineering.Life (Basel). 2021 Sep 30;11(10):1033. doi: 10.3390/life11101033. Life (Basel). 2021. PMID: 34685402 Free PMC article. Review.
-
Use of gene-modified keratinocytes and fibroblasts to enhance regeneration in a full skin defect.Langenbecks Arch Surg. 2011 Apr;396(4):543-50. doi: 10.1007/s00423-011-0761-3. Epub 2011 Mar 3. Langenbecks Arch Surg. 2011. PMID: 21369846
-
Pharmacological Functions, Synthesis, and Delivery Progress for Collagen as Biodrug and Biomaterial.Pharmaceutics. 2023 May 9;15(5):1443. doi: 10.3390/pharmaceutics15051443. Pharmaceutics. 2023. PMID: 37242685 Free PMC article. Review.
-
Wound coverage technologies in burn care: novel techniques.J Burn Care Res. 2013 Nov-Dec;34(6):612-20. doi: 10.1097/BCR.0b013e31829b0075. J Burn Care Res. 2013. PMID: 23877140 Free PMC article. Review.
-
Cost-efficacy of cultured epidermal autografts in massive pediatric burns.Ann Surg. 2000 Jun;231(6):869-76. doi: 10.1097/00000658-200006000-00011. Ann Surg. 2000. PMID: 10816630 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources